Effect of phosphatidylserine on memory in patients and rats with Alzheimer’s disease

Genetics and Molecular Research

Volumn 14, Issue 3, 2015, Pages 9325-9333

  Zhang, Y Y ^a   Yang, L Q ^a   Guo, L M ^a  

^a QIQIHAR MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer s disease; Memory; Phosphatidylserine

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; HYDROXIDE; PHOSPHATIDYLSERINE; SUPEROXIDE DISMUTASE; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HISTOPATHOLOGY; HUMAN; LATENT PERIOD; LEARNING MEMORY; LINGUISTICS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL CAPACITY; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; RAT; TREATMENT OUTCOME; ANIMAL; ANIMAL BEHAVIOR; BRAIN; DISEASE MODEL; METABOLISM; MIDDLE AGED; PATHOLOGY; PSYCHOLOGY; VERY ELDERLY;

RATTUS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MEMORY; MIDDLE AGED; PEPTIDE FRAGMENTS; PHOSPHATIDYLSERINES; RATS;

EID: 84939196615     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2015.August.10.13     Document Type: Article

References (20)

1. Ballard C, Gauthier S, Corbett A, Brayne C, et al. (2011). Alzheimer's disease. Lancet 377: 1019-1031.
2. Cagnin A, Cester A, Costa B, Ermani M, et al. (2014). Effectiveness of switching to the rivastigmine transdermal patch from oral cholinesterase inhibitors: a naturalistic prospective study in Alzheimer's disease. Neurol. Sci. 36: 457-463.
3. Canale C, Seghezza S, Vilasi S, Carrotta R, et al. (2013). Different effects of Alzheimer's peptide Aβ(1-40) oligomers and fibrils on supported lipid membranes. Biophys. Chem. 182: 23-29.
4. Cong L and Jia J (2011). Promoter polymorphisms which regulate ADAM9 transcription protect against sporadic Aizheimer's disease. Neurobiol. Aging 32: 54-62.
5. Grimm MO, Haupenthal VJ, Rothhaar TL, Zimmer VC, et al. (2013). Effect of different phospholipids on alpha-secretase activity in the non-amyloidogenic pathway of Alzheimer's disease. Int. J. Mol. Sci. 14: 5879-5898.
6. Hirayama S, Terasawa K, Rabeler R, Hirayama T, et al. (2014). The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial. J. Hum. Nutr. Diet (Suppl 2): 284-291.
7. Hou Y, Wang Y, Zhao J, Li X, et al. (2014). Smart soup, a traditional Chinese medicine formula, ameliorates amyloid pathology and related cognitive deficits. PLoS One 9: e111215.
8. Izzo NJ, Xu J, Zeng C, Kirk MJ, et al. (2014). Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II:Sigma-2/ PGRMC1 receptors mediate abeta 42 oligomer binding and synaptotoxicity. PLoS One 9: e111899.
9. Liu SH, Chang CD, Chen PH, Su JR, et al. (2012). Docosahexaenoic acid and phosphatidylserine supplementations improve antioxidant activities and cognitive functions of the developing brain on pentylenetetrazol-induced seizure model. Brain Res. 1451: 19-26.
10. Maiese K and Chong ZZ (2004). Lights into oxidative stress and potential novel therapeutic targets for Alzheimer disease. Restor. Neurol. Neurosci. 22: 87-104.
11. Manor I, Magen A, Keidar D, Rosen S, et al. (2012). The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled trial, followed by an open-label extension. Eur. Psychiatr. 27: 335-342.
12. Meng X, Wang M, Sun G, Ye J, et al. (2014). Attenuation of Aβ25-35-induced parallel autophagic and apoptotic cell death by gypenoside XVII through the estrogen receptor-dependent activation of Nrf2/ARE pathways. Toxicol. Appl. Pharmacol. 279: 63-75.
13. Nair S, Traini M, Dawes IW and Perrone GG (2014). Genome-wide analysis of Saccharomyces cerevisiae identifies cellular processes affecting intracellular aggregation of Alzheimer's amyloid-β42: importance of lipid homeostasis. Mol. Biol. Cell 25: 2235-22349.
14. Penolazzi B, Bergamaschi S, Pastore M, Villani D, et al. (2014). Transcranial direct current stimulation and cognitive training in the rehabilitation of Alzheimer disease: A case study. Neuropsychol. Rehabil. 7: 1-19.
15. Richter Y, Herzog Y, Lifshitz Y, Hayun R, et al. (2013). The effect of soybean-derived phosphatidylserine on cognitive performance in elderly with subjective memory complaints: a pilot study. Clin. Interv. Aging 8: 557-563.
16. Sato Y, Nakamura T, Aoshima K and Oda Y (2010). Quantitative and wide-ranging profiling of phospholipids in human plasma by two-dimensional liquid chromatography/mass spectrometry. Anal. Chem. 82: 9858-9864.
17. Schmid D, Grabmer C, Streif D, Lener T, et al. (2014). T-Cell death, phosphatidylserine exposure and reduced proliferation rate to validate extracorporeal photochemotherapy. Vox Sang. 108: 82-88.
18. Suzuki S, Yamatoya H, Sakai M, Kataoka A, et al. (2001). Oral administration of soybean lecithin transphosphatidylated phosphatidylserine improves memory impairment in aged rats. J. Nutr. 131: 2951-2956.
19. Wollen KA (2010). Alzheimer's disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners. Altern. Med. Rev 15: 223-424.
20. Zanotta D, Puricelli S and Bonoldi G (2014). Cognitive effects of a dietary supplement made from extract of Bacopa monnieri, astaxanthin, phosphatidylserine, and vitamin E in subjects with mild cognitive impairment: a noncomparative, exploratory clinical study. Neuropsychiatr. Dis. Treat 10: 225-230.